MedTech News
.................... by Andrew Celentano
Low-dose eye drops can manage adult myopia for 24 hours
Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia.
Omega-3 supplements may be linked to faster cognitive decline in seniors, study finds
A new study published in The Journal of Prevention of Alzheimer’s Disease suggests that these oral capsules may actually be linked to a faster decline in cognitive function.
FDA clears Pfizer, Arvinas’ novel breast cancer therapy despite mixed data
Veppanu, the first PROTAC therapy approved by the FDA, improved progression free survival by 43% versus AstraZeneca’s Faslodex but showed no such significant benefit in the intention-to-treat analysis.
Insulet starts study of closed loop insulin delivery system
Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.
FDA grants 510(k) clearance to TaeWoong Medical for Spaxus EUS stent
TaeWoong Medical, the fully covered, self-expanding metallic device, is intended to aid EUS drainage procedures.
UNM Scientist Studies Where Brain Cancer Cells Hide and How to Fight Them
https://medtechspectrum.com/news/40/25517/unm-scientist-studies-where-brain-cancer-cells-hide-and-how-to-fight-them.html
Scientists recruit red blood cells to deliver genetic cargo with instructions to kill cancer
Scientists have developed a way to turn the body’s own immune cells into cancer-fighting agents—without removing them from the body—by using red blood cells to deliver genetic instructions.
Experimental KRAS G12D drug slows cancer growth, shrinks tumors in early test
A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key cancer-driving protein called KRAS G12D, shows encouraging early activity in patients with advanced lung and pancreatic cancers.